KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study

BACKGROUND: A single nucleotide polymorphism located in the 3'-untranslated region of the KRAS oncogene (KRAS variant; rs61764370) disrupts a let-7 miRNA binding and was recently reported to act as a genetic marker for increased risk of developing human cancers. We aimed to investigate an assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerne, Jasmina-Ziva, Stegel, Vida, Gersak, Ksenija, Novakovic, Srdjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342891/
https://www.ncbi.nlm.nih.gov/pubmed/22436609
http://dx.doi.org/10.1186/1471-2407-12-105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342891/
https://www.ncbi.nlm.nih.gov/pubmed/22436609
http://dx.doi.org/10.1186/1471-2407-12-105

Ejemplares similares